Juvmo cleared for Parkinson's disease in adults

Sponsor

AbbVie $ABBV

Drug

Juvmo · tavapadon

Indication

Parkinson's disease in adults

FDA approved AbbVie's Juvmo (tavapadon), a once-daily D1/D5 dopamine partial agonist pill, for Parkinson's disease in adults.